HIV drug combats resistance
A new class of drug may help meet the growing need for medicines to combat the growing problem of resistant strains of HIV. Trials currently taking place of two drugs in a class known as fusion
Related Content
- Bracing for superbugs: strengthening environmental action in the one health response to antimicrobial resistance
- Global tuberculosis report 2018
- Global tuberculosis report 2017
- Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis
- Alternatives to antibiotics—a pipeline portfolio review
- Most people are clueless about proper use of antibiotics